Other clinical studies have revealed that Th17 cell infiltration and IL-17 expression levels in tumors are associated with tumor progression and poor survival in patients with gastric cancer and hepatocellular carcinoma [128,129]. The gene discussed is IL17A; the disease is neoplasm.